SUBCUTANEOUS ADMINISTRATION OF COAGULATION FACTOR VIIa-RELATED POLYPEPTIDES
AssigneeNovo Nordisk HealthCare A/G
InventorsChristian Rischel, Brit Binow Sorensen, Ralf Henning Stennicke
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a Factor VIIa-related polypeptide for the manufacture of a medicament for treatment of a condition affectable by Factor VIIa, in particular a bleeding episode, said medicament being for subcataneous or intramuscular administration.
Claims8
A method for preventing or treating a bleeding episode, the method comprising administering to a patient in need of such treatment an effective amount for such treatment of a Factor VIIa-related polypeptide, wherein the administering is via a subcutaneous or intramuscular route.
(canceled)
Kit of parts comprising (i) a Factor VIIa-related polypeptide in a pharmaceutical formulation, and (ii) instructions for administering via a subcutaneous or intramuscular route for preventing or treating a bleeding episode.
Dependencies are inferred from the claim text.